Ontology highlight
ABSTRACT: Objective
CD34(+) cells, present within the bone marrow, have previously been shown to possess pancreatic endocrine potential. Based on this observation, we explored the capacity of CD34(+) cells derived in culture from the differentiation of human embryonic stem cells (hESC), for their in vivo pancreatic endocrine capacity.Materials and methods
Sheep were transplanted with hESC-derived CD34(+) cells, as well as nonsorted differentiated cultures. Transplantations were carried out with in utero intraperitoneal injections prior to development of the immune system in the fetus so that tolerance toward foreign antigens was acquired during gestation and persisted in the adult.Results
All cell populations that were tested demonstrated human cellular activity and long-term
SUBMITTER: Goodrich AD
PROVIDER: S-EPMC2880573 | biostudies-literature | 2010 Jun
REPOSITORIES: biostudies-literature